Supplementary Data — Hypochlorous Acid for COVID-19: real-time meta-analysis of 3 studies

@CovidAnalysis, September 2026, Version 1V1
0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Delgado-En.. (RCT) 28% 0.72 [0.65-0.79] recovery 35 (n) 104 (n) Improvement, RR [CI] Treatment Control Delgado-En.. (RCT) 34% 0.66 [0.59-0.75] recovery 35 (n) 104 (n) Delgado-En.. (RCT) 42% 0.58 [0.50-0.68] recovery 35 (n) 104 (n) Delgado-En.. (RCT) 38% 0.62 [0.54-0.71] recovery 35 (n) 104 (n) Delgado-En.. (RCT) 48% 0.52 [0.43-0.63] recovery 35 (n) 104 (n) Delgado-En.. (RCT) 45% 0.55 [0.47-0.66] recovery 35 (n) 104 (n) Delgado-En.. (RCT) 51% 0.49 [0.39-0.60] recovery 35 (n) 104 (n) Panatto (RCT) 37% 0.63 [0.12-3.38] progression 2/20 3/19 Panatto (RCT) 85% 0.15 [0.01-2.65] progression 0/18 3/19 Panatto (RCT) 67% 0.33 [0.06-1.83] progression 2/38 3/19 Panatto (RCT) 29% 0.71 [0.54-0.93] viral+ 34 (n) 15 (n) Panatto (RCT) 30% 0.70 [0.56-0.88] viral+ 34 (n) 15 (n) Gutiérrez-G.. (RCT) 91% 0.09 [0.01-0.72] symp. case 1/84 10/79 Hypochlorous acid COVID-19 outcomes c19early.org September 2026 Favors hypochlorous acid Favors control
Fig. S1. All outcomes.